Farmaten International S.A. (manufacturing, packaging, quality control and batch release of medicinal product)

Ukraine

All drugs from this manufacturer

  • ATOMOXETINE

    The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, adolescents, and adults.

    Dosage form: capsules, hard

    Active substance Dosage
    atomoxetine 10 mg

    ATC: N06BA09

  • ATOMOXETINE

    The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, adolescents, and adults as part of a comprehensive treatment program.

    Dosage form: capsules, hard

    Active substance Dosage
    atomoxetine 40 mg

    ATC: N06BA09

  • ATOMOXETINE®

    The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, adolescents, and adults.

    Dosage form: capsules, hard

    Active substance Dosage
    atomoxetine 18 mg

    ATC: N06BA09

  • ATOMOXETINE®

    The drug is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, adolescents, and adults.

    Dosage form: capsules, hard

    Active substance Dosage
    atomoxetine 25 mg

    ATC: N06BA09